B of A Securities Maintains Buy on Gilead Sciences, Raises Price Target to $172
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
B of A Securities analyst Tim Anderson maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $168 to $172.
B of A Securities analyst Tim Anderson maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $168 to $172.